These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29914046)

  • 1. Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends.
    Micoli F; Adamo R; Costantino P
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
    Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
    Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
    Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoconjugate vaccines: some observations on carrier and production methods.
    MacCalman TE; Phillips-Jones MK; Harding SE
    Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligosaccharide Antigen Conjugation to Carrier Proteins to Formulate Glycoconjugate Vaccines.
    Smith BR; Guo Z
    Methods Mol Biol; 2021; 2183():305-312. PubMed ID: 32959250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
    Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R
    Front Immunol; 2021; 12():719315. PubMed ID: 34594333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
    Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
    Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and Control of Sugar Size in Glycoconjugate Vaccines.
    Stefanetti G; MacLennan CA; Micoli F
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
    Adamo R
    Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Sun X; Stefanetti G; Berti F; Kasper DL
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):193-198. PubMed ID: 30510007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in carbohydrate-based cancer vaccines].
    Huo CX; Ye XS
    Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.
    Avci FY; Li X; Tsuji M; Kasper DL
    Nat Med; 2011 Nov; 17(12):1602-9. PubMed ID: 22101769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic carbohydrate-based vaccines: challenges and opportunities.
    Mettu R; Chen CY; Wu CY
    J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine.
    Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R
    Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-phthalaldehyde based quantification of polysaccharide modification in conjugate vaccines.
    Rajendar B; Reddy MVNJ; Suresh CNV; Rao GS; Matur RV
    J Pharm Biomed Anal; 2024 Apr; 241():115995. PubMed ID: 38309096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
    Berti F; Micoli F
    Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
    De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
    Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.
    Baraldo K; Mori E; Bartoloni A; Norelli F; Grandi G; Rappuoli R; Finco O; Del Giudice G
    Infect Immun; 2005 Sep; 73(9):5835-41. PubMed ID: 16113302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.